Peter Huber began their work experience in 1992 as a Trainee Lab Technican at Grünau Illertissen GmbH. Peter worked there until 1995. In 2000, they joined Nuvisan Pharma Services Group as an Analyst Bioanalytics LCMS and held that position until 2010. From 2010 to 2017, they worked at Nuvisan Pharma Services Group as a Project Manager Bioanalytic. Since March 2017, they have been serving as the Head Method Development and Validation LCMS Bioanalysis at the same company.
Peter Huber attended FH Isny from 1996 to 2000, where they obtained a degree in Chemie with the title of Dipl. Ing. (FH). Later, from 2006 to 2008, they attended Hochschule Neu-Ulm to pursue their MBA degree with a concentration in BWL.
March, 2017 - present
September, 2010
June, 2000
Sr. Director, Biologics Value Chain Lead, Immuno-oncology Franchise at Bristol-Myers Squibb
Associate Vice President at Pyramid Consulting
Senior Associate at Great Schools Partnership
Senior Associate at Great Schools Partnership
Executive Director, ESG & Purpose Communications at Bristol-Myers Squibb
Access the worlds's biggest network of public org charts
Learn more